215 related articles for article (PubMed ID: 4351191)
1. Biochemical and pharmacological aspects of Parkinsonism.
Carlsson A
Acta Neurol Scand Suppl; 1972; 51():11-42. PubMed ID: 4351191
[No Abstract] [Full Text] [Related]
2. Dopaminergic nervous transmission in Parkinson's disease.
Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
[No Abstract] [Full Text] [Related]
3. Actions of levodopa and dopamine in the central nervous system.
Sourkes TL
JAMA; 1971 Dec; 218(13):1909-11. PubMed ID: 4398939
[No Abstract] [Full Text] [Related]
4. [The functional role of amantadine].
Strömberg U; Svensson T
Lakartidningen; 1972 Nov; 69(46):5340-2. PubMed ID: 4650742
[No Abstract] [Full Text] [Related]
5. The role of brain catecholamines in the regulation of ACTH secretion.
Van Loon GR
Adv Neurol; 1974; 5():479-86. PubMed ID: 4374068
[No Abstract] [Full Text] [Related]
6. Drug-induced changes in brain dopamine and their relation to parkinsonism.
Vogt M
Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
[No Abstract] [Full Text] [Related]
7. Monoamines and the regulation of vigilance and sleep.
Putkonen PT
Med Biol; 1974 Jun; 52(3):193-9. PubMed ID: 4370645
[No Abstract] [Full Text] [Related]
8. L-dopa in Parkinsonism. A possible mechanism of action.
Ng LK; Chase TN; Colburn RW; Kopin IJ
Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
[No Abstract] [Full Text] [Related]
9. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
Andén NE
Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
[No Abstract] [Full Text] [Related]
10. Pathological aspects on Parkinson's syndrome.
Steg G
Acta Neurol Scand Suppl; 1972; 51():139-50. PubMed ID: 4268105
[No Abstract] [Full Text] [Related]
11. The relationship between brain norepinephrine and aggressive behavior.
Reis DJ
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():266-97. PubMed ID: 4341950
[No Abstract] [Full Text] [Related]
12. Proceedings: Pharmacology of the adrenergic mechanism.
Pfeifer AK
J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4135935
[No Abstract] [Full Text] [Related]
13. The pharmacology of parkinsonism (a review).
Klawans HL
Dis Nerv Syst; 1968 Dec; 29(12):805-16. PubMed ID: 4388368
[No Abstract] [Full Text] [Related]
14. [The role of dopamine in the physiology and pathology of the basal ganglia].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
[No Abstract] [Full Text] [Related]
15. Recent advances in the treatment of Parkinsonism with drugs.
Rinne UK
Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
[No Abstract] [Full Text] [Related]
16. Functional aspects of 5-hydroxytryptamine turnover in the central nervous system.
Modigh K
Acta Physiol Scand Suppl; 1974; 403():1-56. PubMed ID: 4275711
[No Abstract] [Full Text] [Related]
17. Relationship between animal models and clinical parkinsonism.
Marsden CD; Duvoisin RC; Jenner P; Parkes JD; Pycock C; Tarsy D
Adv Neurol; 1975; 9():165-75. PubMed ID: 1146651
[No Abstract] [Full Text] [Related]
18. [Motor and psychomotor activity of striatal monoamines].
Poirier LJ; Bédard P; Larochelle L
Laval Med; 1970 Sep; 41(7):894-6. PubMed ID: 4994702
[No Abstract] [Full Text] [Related]
19. [Pharmaco-biochemical mechanisms and modern therapy in Parkinsonian syndromes].
Bartholini G; Tissot R
Rev Med Liege; 1970 Sep; 25(18):591-607. PubMed ID: 5511964
[No Abstract] [Full Text] [Related]
20. Biogenic amine-containing neurons: biochemical mechanisms of synaptic transmission.
Neff NG; Yang HY; Garelis E; Sampath SS
Psychother Psychosom; 1974; 23(1-6):159-68. PubMed ID: 4369812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
